New York, New York--(Newsfile Corp. - February 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.SO WHAT: If you purchased agilon securities during the Class Period you may be entitled to compensation without payment of any ou ...

Core Viewpoint - Agilon Health, Inc. is facing a class action lawsuit for securities law violations, specifically for making false and misleading statements regarding its financial guidance and strategic actions [1] Group 1: Lawsuit Details - The class action lawsuit is based on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1] - The class period for the lawsuit is from February 26, 2025, to August 4, 2025, with a deadline for lead plaintiff appointment on March 2, 2026 [1] - The complaint alleges that Agilon's 2026 guidance was unattainable, which the company was aware of when communicating with investors [1] Group 2: Company Misrepresentation - Agilon is accused of overstating the impact of its "strategic actions" intended to mitigate risk [1] - The lawsuit claims that Agilon's public statements were false and materially misleading throughout the class period [1]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased agilon health, inc. securities between February 26, 2025, and August 4, 2025, about the March 2, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased agilon securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the Court by March 2, 2026 [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation [4]. Group 3: Case Allegations - The lawsuit alleges that defendants made false or misleading statements and failed to disclose critical information regarding agilon's financial guidance for 2025, which was deemed unachievable due to known industry challenges [5]. - It is claimed that defendants overstated the positive financial impact of strategic actions taken by agilon, leading to materially false statements about the company's business and prospects [5]. - The lawsuit asserts that when the true information became public, investors suffered damages as a result [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased agilon health, inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who bought agilon securities between February 26, 2025, and August 4, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 2, 2026 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Agilon - The lawsuit alleges that during the Class Period, defendants made false and misleading statements and failed to disclose critical information, including: 1. Reckless issuance of guidance for 2025 that was unlikely to be achieved due to known industry challenges 2. Material overstatement of the financial impact from strategic actions taken by agilon to mitigate risk 3. Overall misleading statements regarding agilon's business, operations, and prospects [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to allegations of violations of federal securities laws, particularly regarding misleading statements and guidance related to the company's financial performance [2][4]. Group 1: Legal Investigation and Claims - The firm is encouraging investors who suffered losses in agilon health between February 26, 2025, and August 4, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against agilon health, with a deadline of March 2, 2026, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that agilon health and its executives made false statements and failed to disclose significant industry challenges, leading to misleading information about the company's business and financial outlook [4]. Group 2: Financial Impact and Stock Performance - On August 4, 2025, agilon health announced the suspension of its full-year 2025 financial guidance, citing more severe industry headwinds than previously anticipated [5]. - Following this announcement, agilon health's stock experienced a significant decline of 51.5% on August 5, 2025 [5]. Group 3: Firm Background and Encouragement for Whistleblowers - Faruqi & Faruqi, LLP has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding agilon health's conduct [7].

Agilon Health Deadline: AGL Investors with Losses in Excess of $100K Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm [Accessibility Statement] Skip NavigationNEW YORK, Feb. 20, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff ...

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- If you suffered a loss on your investment in agilon health, inc. (“agilon” or the “Company”) (NYSE:AGL), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until March 2, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead plaintiff over ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased agilon health, inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1] Group 1: Class Action Details - The Class Period for the agilon securities is from February 26, 2025, to August 4, 2025 [1] - Investors who purchased agilon securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 2, 2026 [3] Group 2: Case Allegations - The lawsuit alleges that defendants made false and misleading statements regarding agilon's financial guidance for 2025, which they knew was unattainable due to industry challenges [5] - It is claimed that defendants overstated the positive financial impact from strategic actions taken by agilon to mitigate risks [5] - As a result, the statements made about agilon's business operations and prospects were materially false and misleading, leading to investor damages when the truth was revealed [5] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and being ranked No. 1 for securities class action settlements in 2017 [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and success in this area [4]

Class Action Filed Against agilon health, inc. (AGL) - March 2, 2026 Deadline to Join - Contact Levi & Korsinsky [Accessibility Statement] Skip NavigationNEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health, inc. investors who were adversely affected by alleged securities fraud between Feb ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired Agilon securities between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- What’s Happening? Brag ...